Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women

CONTEXT: Studies suggest that menopausal hormone therapy (MHT) prevents type 2 diabetes (T2D). The combination of conjugated estrogens (CE) with the selective estrogen receptor modulator bazedoxifene (BZA) is an MHT that improves obesity and T2D in preclinical models of menopausal metabolic syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovre, Dragana, Peacock, Erin, Katalenich, Bonnie, Moreau, Cynthia, Xu, Beibei, Tate, Chandra, Utzschneider, Kristina M, Gautier, Jean-François, Fonseca, Vivian, Mauvais-Jarvis, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676076/
https://www.ncbi.nlm.nih.gov/pubmed/31384719
http://dx.doi.org/10.1210/js.2019-00074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676076/
https://www.ncbi.nlm.nih.gov/pubmed/31384719
http://dx.doi.org/10.1210/js.2019-00074

Ejemplares similares